Search Within

GME, Medicine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (146)
  2. Journal Article (143)
  3. Research Letter (8)
  4. Review (4)
  5. Editorial (3)
Groups
  1. Graduate Medical Education (304)
  2. Human Oncology and Pathogenesis Program (304)
  3. GSK Faculty (300)
  4. Department of Medicine (290)
  5. Hematology-Oncology Fellows (247)
  6. Solid Tumor Oncology Division (202)

More Groups

People
  1. Michael Berger (67)
  2. Nikolaus Schultz (53)
  3. Marc Ladanyi (48)
  4. Marcel Van Den Brink (40)
  5. David Solit (35)
  6. Santosha Vardhana (34)

More People

Years
  1. 2025 (21)
  2. 2024 (75)
  3. 2023 (81)
  4. 2022 (53)
  5. 2021 (17)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Blood (31)
  3. Clinical Cancer Research (20)
  4. Cancer Research (17)
  5. Annals of Oncology (12)
  6. JCO Precision Oncology (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (78)
  2. American Association for Cancer Research (45)
  3. American Society of Hematology (35)
  4. Elsevier Inc. (29)
  5. Nature Publishing Group (24)
  6. Oxford University Press (24)

More Publishers

Results (304)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schöder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Outcomes of stereotactic radiosurgery for colorectal cancer brain metastases
    Meeting Abstract

    Gui, C.; Mueller, K. D.; Eichholz, J. E.; Walch, H.; Khatri, I.; del Balzo, L.; Kemeny, N. E.; Imber, B. S.; Schultz, N.; Foote, M. B.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Tumor immune microenvironment determinants of response to lenvatinib and a PD-1 blockade in clear cell renal cell carcinoma
    Meeting Abstract

    Vuong, L.; Kuo, F.; Jiang, H.; Mascareno, E. A.; Rappold, P.; Sabio, E.; Weiss, K.; Cornish, A.; Reese, S.; Adlesic, M.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • CDC7 inhibition constrains lineage plasticity and prevents resistance and neuroendocrine transformation in the lung and prostate
    Meeting Abstract

    Quintanal-Villalonga, Á.; Zaidi, S.; Karthaus, W. R.; Zhan, Y. A.; Shafer, M.; Qiu, J.; de Stanchina, E.; Haffner, M. C.; Sawyers, C. L.; Rudin, C. M.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Pan-cancer assessment of the impact of intronic variants on cancer development and progression
    Meeting Abstract

    Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save